Sidley Advises on the Hong Kong IPO of Concord Healthcare Group Co., Ltd.

Sidley advised on the initial public offering (IPO) and H share listing of Concord Healthcare Group Co., Ltd. (HKEX: 2453) (Concord Healthcare Group) on the Main Board of the Hong Kong Stock Exchange (HKEX). The offering raised approximately HK$562.9 million (US$72.2 million). Sidley acted as Hong Kong and U.S. counsel for the joint sponsors China International Capital Corporation Hong Kong Securities Limited, Haitong International Capital Limited, and the underwriters.

Concord Healthcare Group is an oncology healthcare service provider in China. It serves both cancer patients through its self-owned medical institutions and third-party medical institutions through its medical equipment, software and related services. In its self-owned medical institutions, the company provides a full spectrum of oncology healthcare services to cancer patients, leveraging its multidisciplinary team specialists and diagnosis and treatment capabilities featuring precision radiation therapy.

The Sidley team was led by partners Meng Ding and Claudia Yu. Other team members included senior associate Kevin Chan, associates Maggie Bai and Yiming Chen, China advisor Junlang Chen, legal manager Lexie Lu, and senior legal assistants Iris Lao, Freddie Feng, Alice Liu and Luting Cui.

Leave a Reply

Your email address will not be published. Required fields are marked *